Drug & intervention
carbidopa
RxCUI 2019
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
carbidopa
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
11 shownHistaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel ApproachNCT03266965 · 2018-03-23
COMPLETEDNorepinephrine-targeted Therapy for Action Control in Parkinson DiseaseNCT03115827 · 2017-04-18
COMPLETEDA Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With AsthmaNCT02633007 · 2015-12-01
COMPLETEDEfficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.NCT01227655 · 2011-03-01
COMPLETEDEfficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" PhenomenonNCT01568073 · 2011-03-01
COMPLETEDComparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensNCT01296464 · 2011-02-01
COMPLETEDA Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease PatientsNCT01229332 · 2011-01-01
COMPLETEDAcute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)NCT00845000 · 2009-04-21
COMPLETEDHigh and Low Dose Carbidopa Treatment of Parkinson's DiseaseNCT01399905 · 2009-03-01
COMPLETEDAugmenting Effects of L-DOPS With Carbidopa and EntacaponeNCT00547911 · 2007-10-01
TERMINATEDTreatment of Supine Hypertension in Autonomic FailureNCT00223717 · 2001-01-01
COMPLETEDConditions being studied
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.